BioLargo Covers its Diverse Portfolio with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - August 19, 2020) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO) ("the Company"), an innovator of technology-based products and environmental engineering solutions provider. BioLargo President & CEO Dennis Calvert joined Stock Day host Everett Jolly.

Jolly began the interview by asking about the Company's 10-Q quarterly report for the period ending on June 30, 2020. "We've got some developments that are going to turn into significant commercial successes," shared Calvert, noting the Company's diversification of its products. "We have a couple of big wins coming to the table, and more after."

Calvert then expanded on the Company's FDA registered personal protection spray Clyraguard. "Clyraguard is a very exciting product. It was developed by our medical subsidiary Clyra Medical," explained Calvert. "It is a [personal protection equipment] (PPE) disinfectant, which is FDA registered, hospital grade, and safe. Literally, you can spray it on your skin and face mask, and it provides an extra layer of protection," said Calvert, adding that the product was proven to inactivate the SARS-CoV-2 (COVID-19) virus in a third party study.

Calvert shared that Clyraguard is in the process of undergoing a multiphase launch. "We have a number of online sellers, and we have some distributors," shared Calvert, adding that a very large distributor is currently preparing to come onboard. "The product is a four ounce bottle. That little bottle lasts about two months," he added, noting that Clyraguard will retail for around $25 per bottle. "There's no odor, stickiness, or residue, and it provides this incredibly effective product."

The conversation then turned to the Company's solution for the current per and polyfluoroalkyl substance (PFAS) water contamination crisis. "The experts say that PFAS touches 98% of the world; it's in your food, it's in your water, it's in products, and it's in coatings," explained Calvert. "Nature won't break them down, and a little bit over a long period of time creates a problem," he added. "Our engineering group came out with a solution, got a grant, proved out the first phase, and we've been advancing that design to be ready for commercialization," said Calvert, before elaborating on the importance and cost of this crisis. "We'll be in commercial trials soon, and it's a significant opportunity."

Calvert then commented on the Company's AOS water treatment technology. "This was another innovative development that provides extremely efficient destruction of micropollutants and efficient disinfection," explained Calvert. "It's a remarkable scientific achievement," said Calvert. He then shared that the Company received a significant funding commitment from a new client, as well as from grant authorities. "The total revenue for the company for that project is going to be about half a million dollars."

To close the interview, Calvert expressed his confidence in the Company's resiliency, as well as the potential of their diversifying portfolio. "We think the future is extraordinarily bright for this company."

To hear Dennis Calvert's entire interview, follow the link to the podcast here: https://audioboom.com/posts/7661365-biolargo-covers-its-diverse-portfolio-with-the-stock-day-podcast.

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/.

About BioLargo, Inc.

BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to "make life better". We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard (www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective against viruses and bacteria, and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act

During the course of the stockholder presentation, BioLargo may make "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995, regarding future events or the future financial performance of the company that are subject to change. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

About The "Stock Day" Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

SOURCE:
Stock Day Media
(602) 821-1102

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/62112